PE20080937A1 - Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil)amino]metil]fenil]-2e-2-propenamida - Google Patents

Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil)amino]metil]fenil]-2e-2-propenamida

Info

Publication number
PE20080937A1
PE20080937A1 PE2007000725A PE2007000725A PE20080937A1 PE 20080937 A1 PE20080937 A1 PE 20080937A1 PE 2007000725 A PE2007000725 A PE 2007000725A PE 2007000725 A PE2007000725 A PE 2007000725A PE 20080937 A1 PE20080937 A1 PE 20080937A1
Authority
PE
Peru
Prior art keywords
methyl
salts
propenamide
indol
hydroxy
Prior art date
Application number
PE2007000725A
Other languages
English (en)
Inventor
Murat Acemoglu
Joginder S Bajwa
Piotr Karpinski
Dimitris Papoutsakis
Joel Slade
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38564366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20080937(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20080937A1 publication Critical patent/PE20080937A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A SALES Y FORMAS CRISTALINAS DEL COMPUESTO N-HIDROXI-3-[4-[[[2-(METIL-1H-INDOL-3-IL)ETIL)]AMINO]METIL]FENIL]-2E-2-PROPENAMIDA, EN DONDE DICHAS SALES SON SELECCIONADAS DE CLORHIDRATO, DL-LACTATO, L-LACTATO, D-LACTATO, MALEATO, MESILATO, TARTRATO, ACETATO, BENZOATO, CITRATO, FUMARATO, GENTISATO, MALATO, MALONATO, OXALATO, FOSFATO, PROPIONATO, SULFATO, SUCCINATO, SODIO, POTASIO, CALCIO Y ZINC. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE LO COMPRENDE, SIENDO UTIL EN EL TRATAMIENTO Y PREVECION DE ENFERMEDADES MEDIADAS POR HISTONA-DESACETILASA
PE2007000725A 2006-06-12 2007-06-08 Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil)amino]metil]fenil]-2e-2-propenamida PE20080937A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80452306P 2006-06-12 2006-06-12
US86999306P 2006-12-14 2006-12-14

Publications (1)

Publication Number Publication Date
PE20080937A1 true PE20080937A1 (es) 2008-08-29

Family

ID=38564366

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000725A PE20080937A1 (es) 2006-06-12 2007-06-08 Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil)amino]metil]fenil]-2e-2-propenamida

Country Status (38)

Country Link
US (3) US20090197936A1 (es)
EP (1) EP2032531B1 (es)
JP (2) JP2009540005A (es)
KR (2) KR20090026281A (es)
AR (1) AR061298A1 (es)
AU (1) AU2007257962B2 (es)
BR (1) BRPI0712771A2 (es)
CA (1) CA2654439C (es)
CL (1) CL2007001692A1 (es)
CR (1) CR10439A (es)
DK (1) DK2032531T3 (es)
EA (1) EA015212B1 (es)
EC (1) ECSP088979A (es)
ES (1) ES2570934T3 (es)
GE (1) GEP20105125B (es)
GT (1) GT200800279A (es)
HK (1) HK1126496A1 (es)
HN (1) HN2008001859A (es)
HR (1) HRP20160291T1 (es)
HU (1) HUE027126T2 (es)
IL (1) IL195087A (es)
JO (1) JO3138B1 (es)
MA (1) MA30563B1 (es)
ME (1) ME00531B (es)
MX (1) MX2008015901A (es)
MY (1) MY147345A (es)
NO (1) NO341871B1 (es)
NZ (1) NZ572547A (es)
PE (1) PE20080937A1 (es)
PL (1) PL2032531T3 (es)
RS (1) RS54640B1 (es)
SI (1) SI2032531T1 (es)
SM (1) SMP200900002B (es)
SV (1) SV2008003126A (es)
TN (1) TNSN08501A1 (es)
TW (1) TWI409254B (es)
UY (1) UY30403A1 (es)
WO (1) WO2007146715A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0712993A2 (pt) 2006-06-12 2012-04-17 Novartis Ag polimorfos de n-hidróxi-3-[4[[[2-(2-metil-1h-indol-3-il) etil]amino]metil]fenil]-2e-2-propenamida
MX2009007343A (es) * 2007-01-10 2009-07-15 Novartis Ag Formulaciones de inhibidores de desacetilasa.
US8003700B2 (en) * 2008-04-07 2011-08-23 Mutual Pharamaceutical Company, Inc. Colchicine solid complex; methods of making; and methods of use thereof
US8519002B2 (en) 2008-04-07 2013-08-27 Takeda Pharmaceuticals U.S.A., Inc. Colchicine solid complex; methods of making; and methods of use thereof
UY32297A (es) * 2008-12-22 2010-05-31 Almirall Sa Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
JP5263211B2 (ja) 2010-03-30 2013-08-14 ブラザー工業株式会社 サーバ、プリンタ、及び、サーバのためのコンピュータプログラム
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
MA41544A (fr) 2015-02-19 2017-12-26 Novartis Ag Dosages de panobinostat pour le traitement du myélome multiple
WO2017221163A1 (en) * 2016-06-21 2017-12-28 Alembic Pharmaceuticals Limited Novel salts and polymorphic forms of panobinostat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
WO2005013958A1 (en) * 2003-08-07 2005-02-17 Novartis Ag Histone deacetylase inhibitors as immunosuppressants
US20050228300A1 (en) * 2004-04-07 2005-10-13 Triage Data Networks Cuffless blood-pressure monitor and accompanying wireless mobile device
JP2009540007A (ja) * 2006-06-12 2009-11-19 ノバルティス アクチエンゲゼルシャフト Ｎ−ヒドロキシ−３−［４−［［［２−（２−メチル−１ｈ−インドール−３−イル）エチル］アミノ］メチル］フェニル］−２ｅ−２−プロペンアミドの塩の製造方法
BRPI0712993A2 (pt) * 2006-06-12 2012-04-17 Novartis Ag polimorfos de n-hidróxi-3-[4[[[2-(2-metil-1h-indol-3-il) etil]amino]metil]fenil]-2e-2-propenamida

Also Published As

Publication number Publication date
KR101629352B1 (ko) 2016-06-13
KR20090026281A (ko) 2009-03-12
TWI409254B (zh) 2013-09-21
AU2007257962A1 (en) 2007-12-21
WO2007146715A1 (en) 2007-12-21
RS54640B1 (en) 2016-08-31
HK1126496A1 (zh) 2009-09-04
UY30403A1 (es) 2008-01-31
IL195087A (en) 2012-10-31
AU2007257962B2 (en) 2011-06-23
CA2654439A1 (en) 2007-12-21
EA200802382A1 (ru) 2009-06-30
SI2032531T1 (sl) 2016-05-31
NO20090128L (no) 2009-03-11
IL195087A0 (en) 2009-08-03
JP2013256542A (ja) 2013-12-26
NO341871B1 (no) 2018-02-12
MX2008015901A (es) 2009-01-12
JO3138B1 (ar) 2017-09-20
HUE027126T2 (en) 2016-08-29
TNSN08501A1 (en) 2010-04-14
KR20150029765A (ko) 2015-03-18
EP2032531B1 (en) 2016-02-10
BRPI0712771A2 (pt) 2012-09-25
US20090197936A1 (en) 2009-08-06
JP5771257B2 (ja) 2015-08-26
HN2008001859A (es) 2011-07-19
TW200815343A (en) 2008-04-01
EP2032531A1 (en) 2009-03-11
EA015212B1 (ru) 2011-06-30
CR10439A (es) 2009-01-15
NZ572547A (en) 2011-06-30
DK2032531T3 (en) 2016-04-11
CL2007001692A1 (es) 2008-05-09
US20110112308A1 (en) 2011-05-12
JP2009540005A (ja) 2009-11-19
ECSP088979A (es) 2009-01-30
PL2032531T3 (pl) 2016-07-29
ME00531B (me) 2011-10-10
MY147345A (en) 2012-11-30
GT200800279A (es) 2010-06-16
GEP20105125B (en) 2010-11-25
AR061298A1 (es) 2008-08-20
CA2654439C (en) 2014-08-05
MA30563B1 (fr) 2009-07-01
HRP20160291T1 (hr) 2016-04-22
US20100286409A1 (en) 2010-11-11
ES2570934T3 (es) 2016-05-23
SMAP200900002A (it) 2009-01-14
SV2008003126A (es) 2011-07-05
SMP200900002B (it) 2010-01-19

Similar Documents

Publication Publication Date Title
PE20080937A1 (es) Sales de n-hidroxi-3-[4-[[[2-(2-metil-1h-indol-3-il)etil)amino]metil]fenil]-2e-2-propenamida
TN2012000125A1 (en) Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors
PE20141124A1 (es) Derivados de imidazol fusionados, utiles como inhibidores de ido
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
AR048361A1 (es) Derivados de tetrahidroquinolina y un procedimiento para preparar los mismos
EA201101398A1 (ru) Замещенные пиперидины в качестве антагонистов ccr3
PE20110574A1 (es) Derivados de fenilamida y de piridilamida como agonistas de gpbar1
MY151295A (en) Pyrimidyl indoline compound
RU2585622C3 (ru) Тетрациклические соединения
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
TN2013000309A1 (en) Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
MX2011012628A (es) Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
MX2013005533A (es) Derivados de acido amino-bisfenil-pentanoico sustituidos como inhibidores de nep.
TW200616953A (en) Indole, indazole or indoline derivatives
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
PE20142244A1 (es) Inhibidores de pirazolopirimidinilo de enzima activadora de ubiquitina
EA201070442A1 (ru) НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ
AR061295A1 (es) Procedimiento para hacer sales de n-hidroxi-3- [4-[ [ [ 2- ( 2-metil-1h-indol-3-il) etil] amino] metil] fenil] -2e-2-propenamida
AR072718A1 (es) Uso de derivados de indol tales como los activadores de nurr-1 para el tratamiento de la enfermedad de parkinson
TW200716597A (en) Novel piperidine-substituted indoles
MY148393A (en) Malate salts, and polymorphs of (3s, 5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid

Legal Events

Date Code Title Description
FG Grant, registration